Report Description
A recent market
intelligence report that is published by Data Insights Partner on Cancer
Vaccines market makes an
offering of in-depth analysis of segments and sub-segments in the regional and
international Cancer Vaccines market. The research
also emphasizes on the impact of restraints, drivers, and macro indicators on
the regional and world Cancer Vaccines market over the short
as well as long period of time. A detailed presentation of forecast, trends,
and dollar values of international Cancer Vaccines market is offered. In accordance with the report, the global Cancer
Vaccines market is projected to expand at a CAGR of 15% over the period of forecast.
Market Insight, Drivers, Restraints&
Opportunity of the Market:
Cancer vaccines
are the vaccines which use to prevent or treat existing cancer (such as
cervical cancer, some types of liver cancer). Currently HPV vaccines and
Hepatitis B vaccines are available in the market. With emergence of Human Papilloma Virus (HPV)
and Hepatitis virus, several companies are continuously engaged in the
manufacturing of new and effective cancer vaccines. In addition, BCG vaccines
are considered as one of the effective treatment options for treating bladder
cancer. The demand for cancer vaccines is on the rise due to rising number of
cervical cancer, anal cancer, prostate cancer, some types of liver cancer,
government support for the development of cancer vaccines.
Rapidly increasing incidence of cervical
cancer, anal cancer, prostate cancer, liver cancer, bladder cancer etc. is
likely to propel the growth of cancer vaccines market. According to the WHO, cervical cancer is the
fourth most cause of death among female cancer. In the US, approximately
500,000 women are being affected with cervical cancer which represents almost
5-7% of the entire female cancer. In 2018, 80% of the death cases from cervical
cancer was found from the developing countries. Furthermore, prostate cancer is
another global concern for men- recently, the new cases of prostate cancer has exceeded
the incidence of breast cancer in the U.K, revealed by BBC. Healthcare
infrastructure is another prime factor to influence the diagnosis and treatment
rate of cancer. High income countries such as the U.K., the U.S., Germany,
France etc. have been witnessing high diagnosis and treatment rate as those
countries have robust healthcare infrastructure.
Strict Intellectual Property Rights (IPR) law is another prime concern
for the cancer vaccine makers. Under section 3-D of Indian Patent law, mere
discovery of the new form or new substance of vaccine, would not be patentable
if the efficacy of the new form of the vaccine is not properly enhanced for
preventing or treating cancer. In addition, the cancer vaccine markers can’t commercialize
the vaccines at the cost which can’t be afforded by the common people of India,
according to the “Compulsory Licensing” rule under Indian Patent Act.
Furthermore, stringent regulatory landscape is another issue for the cancer
vaccines maker. In 2001, the United States of District Court for the Southern
District of Ohio ordered Amscot Medical Laboratory, Inc. to recall the
Hepatitis B vaccine for improper storage, risk of adulteration and not
complying cGMP rules.
The vaccines makers such as
Merck, Glaxo Smith Kleine (GSK), etc. have been investing a significant amount
in research and development for vaccines. For example, almost 60% growth in
R&D investment in 2017 as compared to the last year has been witnessed by Merck,
or over 25% growth in R&D investment in 2017 as compared to 2016 has been
shown displayed by Glaxo Smith Kliene (GSK). In addition, other prominent
companies have been rigorously working on cancer vaccines- for example,
Pfizer’s prostate cancer vaccine in phase 2, Aduro Biotech’s multiple myeloma
vaccine in phase 1 etc. Several
partnerships, mergers and acquisitions activities have been observed in the
cancer vaccines industry. For example, the Sanpower Group, a Chinese private
equity firm acquired Valeant Pharmaceutical’s blockbuster prostate cancer
vaccine, Provengne in 2016 or Ephiphany, Merck and Pfizer collaborated to
progress a study on breast cancer vaccines in 2017. Furthermore, CSL Pharma, a
Melbourne based vaccine maker obtained marketing opportunity of GARDASIL in
some specific countries. In April 2019, Vaccibody’s VB10.NEO and Nektar
Therapeutics has collaborated in order to induce a strong immune response
against cancer cells, in particular in a mouse model of colon cancer.
Segment Covered:
This market
intelligence report on the global Cancer Vaccines market encompasses market
segments based on technology, type, indication, end user and geography. On the
basis of technology, the sub-markets is segmented into whole cell cancer
vaccines, dendritic cells cancer vaccines, antigen/adjuvant cancer vaccines,
recombinant cancer vaccines, viral vector & DNA cancer vaccines . Furthermore,
the global Cancer Vaccines market is broken down into preventive and
therapeutic cancer vaccines, by type. By indication, the global Cancer Vaccines
market is segregated into prostate cancer, cervical cancer and others. In terms
of end user, the global Cancer Vaccines market is divided into adult and
pediatric cancer vaccines. By Geography, the global Cancer Vaccines market
has been divided into North America (the U.S., Canada), Latin America (Brazil,
Mexico, Argentina and other countries), Europe (Germany, France, the U.K.,
Spain, Italy, Russia, and other countries), Asia Pacific (India, Japan, China,
Australia and New Zealand and other countries), Middle East and Africa (GCC,
South Africa, Israel and Other countries).
Profiling of Market
Players:
This business
intelligence report offers profiling of reputed companies that are operating in
the market. Companies such as Aduro Biotech, AstraZeneca Plc, Merck & Co.,
Inc., GlaxoSmithKline Plc, Pfizer, Inc., Sanofi, CSL Limited, Astellas Pharma
Inc., Serum Institute of India Pvt Ltd., The Sanpower Group, Heat Biologics,
TapImmune, Bavarian Nordic, GreenSignal Biopharma Pvt Ltd., Organon Technica
Corp LLc., VBI Vaccines Inc., Cipla Limited,GeoVax Labs, Inc., Yeda Research,
Carogen Corporation etc. among others have been profiled into detail so as to
offer a glimpse of the market leaders. Moreover, parameters such as Cancer
Vaccines market related investment & spending and developments by major
players of the market are tracked in this global report.
Report Highlights:
In-depth
analysis of the micro and macro indicators, market trends, and forecasts of
demand is offered by this business intelligence report. Furthermore, the report
offers a vivid picture of the factors that are steering and restraining the
growth of this market across all geographical segments. In addition to that, IGR-Growth
Matrix analysis is also provided in the report so as to share insight of the
investment areas that new or existing market players can take into consideration.
Various analytical tools such as DRO analysis, Porter's five forces analysis has
been used in this report to present a clear picture of the market. The study
focuses on the present market trends and provides market forecast from the year
2017-2027. Emerging trends that would shape the market demand in the years to
come have been highlighted in this report. A competitive analysis in each of
the geographical segments gives an insight into market share of the global
players.
Salient Features:
Ø
This study offers
comprehensive yet detailed analysis of the Cancer Vaccines market, size of the market (US$ Mn), and Compound Annual Growth
Rate (CAGR (%)) for the period of forecast: 2019 – 2027, taking into account
2018 as the base year
Ø
It explains upcoming
revenue opportunities across various market segments and attractive matrix of
investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, launch of new products, competitive market strategies of
leading market players, emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world Cancer Vaccines market is done by taking into account various parameters such as
company strategies, distribution strategies, product portfolio, financial
performance, key developments, geographical presence, and company overview
Ø
Leading
market players covered this report comprise names such as. Aduro Biotech, AstraZeneca Plc, Merck & Co., Inc.,
GlaxoSmithKline Plc, Pfizer, Inc., Sanofi, CSL Limited, Astellas Pharma Inc.,
Serum Institute of India Pvt Ltd., The Sanpower Group, Heat Biologics,
TapImmune, Bavarian Nordic, GreenSignal Biopharma Pvt Ltd., Organon Technica
Corp LLc., VBI Vaccines Inc., Cipla Limited,GeoVax Labs, Inc., Yeda Research,
Carogen Corporation and among others
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of products, government
initiatives, marketing tactics and expansion, and technical up gradation
Ø
The world market
for Cancer
Vaccines market caters to the needs of various stakeholders
pertaining to this industry, namely suppliers, manufacturers, investors, and
distributors for Cancer Vaccines market. The research
also caters to the rising needs of consulting and research firms, financial
analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the
investment opportunities in the Cancer Vaccines market
v
Identification
of key factors driving investment opportunities in the Cancer Vaccines
market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position
yourself to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects
v
Identify key
strengths and weaknesses of important market participants